Fulgent Genetics EPS - Earnings per Share 2015-2025 | FLGT
Fulgent Genetics eps - earnings per share from 2015 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Fulgent Genetics Annual EPS | |
|---|---|
| 2024 | $-1.41 |
| 2023 | $-5.63 |
| 2022 | $4.63 |
| 2021 | $16.38 |
| 2020 | $8.91 |
| 2019 | $-0.02 |
| 2018 | $-0.31 |
| 2017 | $-0.14 |
| 2016 | $-1.00 |
| 2015 | $-0.61 |
| 2014 | $0.00 |
| Fulgent Genetics Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.37 |
| 2024-12-31 | $-0.19 |
| 2024-09-30 | $-0.48 |
| 2024-06-30 | $-0.29 |
| 2024-03-31 | $-0.45 |
| 2023-12-31 | $-4.29 |
| 2023-09-30 | $-0.44 |
| 2023-06-30 | $-0.38 |
| 2023-03-31 | $-0.52 |
| 2022-12-31 | $-0.73 |
| 2022-09-30 | $0.06 |
| 2022-06-30 | $0.37 |
| 2022-03-31 | $4.93 |
| 2021-12-31 | $3.34 |
| 2021-09-30 | $3.93 |
| 2021-06-30 | $2.59 |
| 2021-03-31 | $6.52 |
| 2020-12-31 | $6.88 |
| 2020-09-30 | $1.98 |
| 2020-06-30 | $0.14 |
| 2020-03-31 | $-0.09 |
| 2019-12-31 | $-0.02 |
| 2019-09-30 | $0.08 |
| 2019-06-30 | $0.02 |
| 2019-03-31 | $-0.10 |
| 2018-12-31 | $-0.11 |
| 2018-09-30 | $-0.03 |
| 2018-06-30 | $-0.06 |
| 2018-03-31 | $-0.11 |
| 2017-12-31 | $-0.09 |
| 2017-09-30 | $-0.06 |
| 2017-06-30 | $0.00 |
| 2017-03-31 | $0.01 |
| 2016-12-31 | $0.15 |
| 2016-09-30 | $-0.44 |
| 2016-06-30 | $-0.66 |
| 2016-03-31 | $-0.05 |
| 2015-12-31 | $0.00 |
| 2015-09-30 | $0.00 |
| 2015-06-30 | $0.00 |
| 2014-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.599B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.313B | 58.92 |
| Tempus AI (TEM) | United States | $11.516B | 0.00 |
| Doximity (DOCS) | United States | $11.474B | 53.12 |
| Hims & Hers Health (HIMS) | United States | $11.060B | 114.91 |
| IRhythm Technologies (IRTC) | United States | $4.939B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.905B | 61.02 |
| Hinge Health (HNGE) | United States | $3.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.682B | 183.33 |
| Enovis (ENOV) | United States | $1.815B | 10.12 |
| Phreesia (PHR) | United States | $1.695B | 0.00 |
| Schrodinger (SDGR) | United States | $1.512B | 0.00 |
| 10x Genomics (TXG) | United States | $1.444B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.405B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 65.09 |
| Omnicell (OMCL) | United States | $1.376B | 24.28 |
| Evolent Health (EVH) | United States | $1.310B | 111.60 |
| Claritev (CTEV) | United States | $0.716B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.452B | 0.00 |
| TruBridge (TBRG) | United States | $0.349B | 773.33 |
| Outset Medical (OM) | United States | $0.338B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.265B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.167B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.109B | 0.00 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| 111 (YI) | China | $0.060B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |